Excerpt from Temporomandibular DisordersSynonyms, Key Words, and Related Terms: TMJ syndrome, TMJ syndrome, temporomandibular joint syndrome, TMJ disease, temporomandibular joint disorder, TMJD, Costen's syndrome, Costen syndrome, temporomandibular disorders, jaw clenching, bruxism, jaw pain, jaw bone disorder, degenerative joint disease, DJD, rheumatoid arthritis, RA, ankylosis, jaw dislocations, jaw infections, neoplasia Please click here to view the full topic text: Temporomandibular DisordersBackgroundThe joint The normal human skull has 2 temporomandibular joints (TMJs), one on the right and one on the left. They connect the skull to the lower jaw bone (the mandible) so as to allow the mouth to open and close. The TMJ is a gliding joint, formed by the condyle of the mandible and the squamous portion of the temporal bone. The articular surface of the temporal bone consists of a convex articular eminence anteriorly and a concave articular fossa posteriorly. The articular surface of the mandible consists of the top of the condyle. Articular surfaces of the mandible and temporal bone are separated by an articular disk, which divides the joint cavity into 2 small spaces. The articular disk, also known as the meniscus, is a biconcave, fibrocartilaginous structure, which provides the gliding surface for the mandibular condyle, resulting in smooth joint movement. The meniscus has 3 parts—a thick anterior band, a thin intermediate zone, and a thick posterior band. With the mouth closed, the condyle is separated from the articular fossa of the temporal bone by the thick posterior band. When the mouth is open, the condyle is separated from the articular eminence of the temporal bone by the thin intermediate zone. The syndrome Temporomandibular disorder(s) (TMD) or temporomandibular joint (TMJ) syndrome is the most common cause of facial pain after toothache. In the past, many physicians called this condition TMJ disease or TMJ syndrome. Even earlier, it was called Costen syndrome after Dr. James Costen who elucidated many aspects of the syndrome in 1934, with a predominant emphasis on dental malocclusion. Today, a much more comprehensive view of this condition exists, and the term temporomandibular disorder (TMD) is the preferred term according to the American Academy of Orofacial Pain (AAOP) and most other groups who sponsor studies into its origins and treatment. Interestingly, the National Institute of Dental and Craniofacial Research (NIDCR) puts TMJ and TMD together and refers to them as temporomandibular joint disorder (TMJD) on its Web site. The authors preferentially use the term temporomandibular disorder (TMD) in this article. No unequivocal definition of the disease exists. However, despite discrepancies concerning the terminology and definitions, a reasonably congruent outlook has emerged among those who study and treat this problem. Two widely used classification schemes exist. The AAOP classification divides TMD broadly into 2 syndromes: (1) muscle-related TMD (myogenous TMD), sometimes this is called TMD secondary to myofacial pain and dysfunction (MPD), and (2) joint-related (arthrogenous) TMD, that is TMD secondary to true articular disease. The 2 types can be present at the same time, making diagnosis and treatment more challenging. Myogenous TMD is more common. In its pure form, it lacks apparent destructive changes of the TMJ on radiograph and can be caused by multiple etiologies such as bruxism and daytime jaw clenching in a stressed and anxious person. Arthrogenous TMD can be further specified as disk displacement disorder, chronic recurrent dislocations, degenerative joint disorders (DJDs), systemic arthritic conditions, ankylosis, infections, and neoplasia. The Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) also exist. The RDC/TMD criteria comprise a highly structured method (ie, algorithms) of obtaining a diagnosis along two separate axes. The Axis I score provides what is considered the clinical diagnosis, and the Axis II score provides an assessment of mandibular function, psychological status, and level of TMD-related psychosocial disability. This discussion emphasizes the terminology and viewpoint of the AAOP approach. However, the authors are mindful of the important features of the RDC/TMD system. As is the case for most diseases and syndromes, the effect on the patient's life is a major feature of the problem and the psychological and psychosocial aspects are of great importance. PathophysiologyIn myogenous TMD, the cause of the symptomatology (ie, pain, tenderness, and spasm of the mastication muscles) is muscular hyperactivity and dysfunction due to malocclusion of variable degree and duration. Psychological factors may also play a role. In TMD of articular origin, disk displacement is the most common cause. Abnormal anterior displacement and interposition of the posterior band between the condyle and the eminence cause pain, pops, and crepitus. If the anteriorly displaced posterior band spontaneously returns to the normal position before the completion of jaw opening, it is called anterior displacement with reduction. The sudden reduction of the posterior band causes the characteristic pop or click. If the posterior band remains anteriorly displaced at all times during jaw opening, it is called anterior displacement without reduction; full jaw opening may not be possible. Inability to attain a jaw opening of more than 10 mm is known as closed lock. In TMD of articular origin, the spasm of the mastication muscle is secondary in nature. The other causes of arthrogenous TMD are diseases such as degenerative joint disease (DJD), rheumatoid arthritis (RA), ankylosis, dislocations, infections, and neoplasia, the pathophysiology of which are self-explanatory. One study found that, in patients with chronic inflammatory connective tissue disease, the pain on mandibular movement and tenderness on posterior palpation of TMJ was related to the level of tumor necrosis factor alpha in the synovial fluid. In a separate study, interleukin 1 receptor antagonist (IL-1ra) and soluble IL-1 receptor II (sIL-1RII) in the synovial fluid and blood plasma of patients with TMJ involvement of polyarthritis appeared to influence the TMJ inflammation. An important development may connect some of the psychosocial aspects of the disease to underlying neurobiology. This is the discovery that the likelihood of a patient being diagnosed with TMD is related to his or her genetic variants (haplotypes) of the gene coding for catecholamine-O-methyltransferase (COMT), a gene that relates, among other things, to some aspects of pain sensitivity. FrequencyUnited StatesTMD is a commonly seen condition in primary care and dentistry practice. According to some authorities, as many as 75% of the people in the United States population will at some time have some of the signs and symptoms of TMD; however, all of these individuals are not believed to have TMD. Between 5% and 10% of Americans may sufficiently fulfill the criteria to merit a diagnosis of TMD. RaceIn a recent study of young women aged 19-23 years, facial pain and jaw symptoms related to TMDS were noted more frequently in Caucasians than in African Americans. Such symptoms also had an earlier onset in Caucasians. SexTMD primarily affects women, more so young women. The male-to-female ratio is 1:4. AgeHighest incidence is among young adults, especially women aged 20-40 years. Please click here to view the full topic text: Temporomandibular Disorders |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |